NCT05687851View on ClinicalTrials.gov

Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 29, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 31, 2026

Conditions
Locally Advanced Cervical Cancer
Interventions
DRUG

Cadonilimab（AK104）

q3w iv

RADIATION

EBRT

45-50.4Gy

RADIATION

BT

≥80Gy

Trial Locations (1)

400000

RECRUITING

Chongqing university Cancer Hospital, Chongqing

All Listed Sponsors
collaborator

Liaoning Cancer Hospital & Institute

OTHER

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

Fujian Cancer Hospital

OTHER_GOV

lead

Chongqing University Cancer Hospital

OTHER

NCT05687851 - Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer | Biotech Hunter | Biotech Hunter